We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Omnicell
OMCL
$1.86B
| $693K | ﹤0.01% |
7,966
+1,039
| +15% | +$109K |
|
|
ETRN
802
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $693K | ﹤0.01% |
92,751
+895
| +1% | +$7.49K |
|
803
PTC Therapeutics
PTCT
$6.37B
| $691K | ﹤0.01% |
13,763
+314
| +2% | +$15.4K |
|
|
VMW
804
DELISTED
VMware, Inc
VMW
| $690K | ﹤0.01% |
6,477
-1,476
| -19% | -$170K |
|
805
Hubbell
HUBB
$25.7B
| $687K | ﹤0.01% |
3,082
-27
| -0.9% | -$5.67K |
|
806
Range Resources
RRC
$9.11B
| $687K | ﹤0.01% |
27,182
+12,961
| +91% | +$392K |
|
807
Starwood Property Trust
STWD
$6.12B
| $684K | ﹤0.01% |
37,547
-1,772
| -5% | -$40.1K |
|
808
Repligen
RGEN
$7.44B
| $682K | ﹤0.01% |
3,644
-34
| -0.9% | -$7.17K |
|
809
Coinbase
COIN
$41.7B
| $681K | ﹤0.01% |
+10,559
| New | +$737K |
|
810
Haemonetics
HAE
$3.58B
| $681K | ﹤0.01% |
9,219
-134
| -1% | -$9.62K |
|
811
Novanta
NOVT
$5.04B
| $678K | ﹤0.01% |
5,865
+1,874
| +47% | +$255K |
|
|
LNW
812
DELISTED
Light & Wonder
LNW
| $675K | ﹤0.01% |
15,763
-717
| -4% | -$35.4K |
|
813
Fidelity National Financial
FNF
$13.9B
| $672K | ﹤0.01% |
19,298
-1,377
| -7% | -$51.4K |
|
814
RBC Bearings
RBC
$18.8B
| $671K | ﹤0.01% |
3,225
-68
| -2% | -$15.7K |
|
|
SF
815
Stifel
SF
$12.3B
| $671K | ﹤0.01% |
19,383
-723
| -4% | -$28.5K |
|
|
CCXI
816
DELISTED
ChemoCentryx, Inc.
CCXI
| $671K | ﹤0.01% |
13,012
+369
| +3% | +$15.3K |
|
817
Penumbra
PEN
$12.5B
| $668K | ﹤0.01% |
3,521
+236
| +7% | +$37.9K |
|
818
Houlihan Lokey
HLI
$9.68B
| $667K | ﹤0.01% |
8,849
-412
| -4% | -$33.4K |
|
819
Jefferies Financial Group
JEF
$12.9B
| $667K | ﹤0.01% |
23,677
-1,527
| -6% | -$46.2K |
|
|
SNV
820
DELISTED
Synovus
SNV
| $664K | ﹤0.01% |
17,707
-572
| -3% | -$22.7K |
|
821
Lantheus
LNTH
$6.82B
| $662K | ﹤0.01% |
9,405
-241
| -2% | -$18.3K |
|
822
Beam Therapeutics
BEAM
$2.58B
| $661K | ﹤0.01% |
13,865
+494
| +4% | +$28.2K |
|
823
LXP Industrial Trust
LXP
$3.53B
| $660K | ﹤0.01% |
14,409
-937
| -6% | -$48.7K |
|
824
EXL Service
EXLS
$4.23B
| $659K | ﹤0.01% |
22,360
-605
| -3% | -$19.7K |
|
|
CHX
825
DELISTED
ChampionX
CHX
| $658K | ﹤0.01% |
33,617
-515
| -2% | -$10.6K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.